These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment]. Cullen P; Schulte H; Assmann G Dtsch Med Wochenschr; 2005 Sep; 130(39):2220-5. PubMed ID: 16189760 [No Abstract] [Full Text] [Related]
3. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)]. Motz W MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487 [No Abstract] [Full Text] [Related]
4. Changing face of dyslipidemia therapy. Banerjee AK Indian Heart J; 2008; 60(3):192-4. PubMed ID: 19240305 [No Abstract] [Full Text] [Related]
6. The case for medical treatment in chronic stable coronary artery disease. Nash DT Arch Intern Med; 2005 Dec 12-26; 165(22):2587-9, discussion 2593-4. PubMed ID: 16344414 [No Abstract] [Full Text] [Related]
7. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Aikawa M; Libby P Cardiovasc Pathol; 2004; 13(3):125-38. PubMed ID: 15081469 [No Abstract] [Full Text] [Related]
8. The power of statins: aggressive lipid lowering. Jones PH Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597 [TBL] [Abstract][Full Text] [Related]
9. Combining niacin with statins: does it help heart health? Johns Hopkins Med Lett Health After 50; 2011 Dec; 23(10):1-2. PubMed ID: 22216465 [No Abstract] [Full Text] [Related]
11. Lipid management with statins. The lower the better? Laufs U; Liao JK; Böhm M Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235 [TBL] [Abstract][Full Text] [Related]
12. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study. Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A; Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia. Jones PH; McKenney JM; Karalis DG; Downey J Am Heart J; 2005 Jan; 149(1):e1. PubMed ID: 15660024 [TBL] [Abstract][Full Text] [Related]
14. Impact of fluvastatin on hyperlipidemia after renal transplantation. Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777 [TBL] [Abstract][Full Text] [Related]
16. [Hyperlipidemia: decreasing lipid values and effects of statins]. Mathes P Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762 [No Abstract] [Full Text] [Related]
17. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts]. MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509 [No Abstract] [Full Text] [Related]
18. [What other effects do statins have except their effect on lipids?]. Tikkanen MJ Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256 [No Abstract] [Full Text] [Related]
19. Updated guidelines support even lower cholesterol levels for at-risk patients. Levenson D Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342 [No Abstract] [Full Text] [Related]
20. [Clinical trials on protective efficacy of statins for cardiovascular events due to hyperlipidemia (J-LIT, 4S, CARE, LIPID etc)]. Higashikata T Nihon Rinsho; 2004 Mar; 62 Suppl 3():628-36. PubMed ID: 15171447 [No Abstract] [Full Text] [Related] [Next] [New Search]